S&P 500   3,093.19 (-0.03%)
DOW   27,788.19 (+0.02%)
QQQ   201.08 (-0.25%)
CGC   15.95 (-13.78%)
BABA   183.04 (+0.31%)
GE   11.25 (-0.35%)
T   39.01 (-0.38%)
F   8.87 (+0.57%)
ACB   3.32 (-6.48%)
PRI   128.22 (-0.30%)
BAC   32.75 (-0.15%)
DIS   149.26 (+0.36%)
S&P 500   3,093.19 (-0.03%)
DOW   27,788.19 (+0.02%)
QQQ   201.08 (-0.25%)
CGC   15.95 (-13.78%)
BABA   183.04 (+0.31%)
GE   11.25 (-0.35%)
T   39.01 (-0.38%)
F   8.87 (+0.57%)
ACB   3.32 (-6.48%)
PRI   128.22 (-0.30%)
BAC   32.75 (-0.15%)
DIS   149.26 (+0.36%)
S&P 500   3,093.19 (-0.03%)
DOW   27,788.19 (+0.02%)
QQQ   201.08 (-0.25%)
CGC   15.95 (-13.78%)
BABA   183.04 (+0.31%)
GE   11.25 (-0.35%)
T   39.01 (-0.38%)
F   8.87 (+0.57%)
ACB   3.32 (-6.48%)
PRI   128.22 (-0.30%)
BAC   32.75 (-0.15%)
DIS   149.26 (+0.36%)
S&P 500   3,093.19 (-0.03%)
DOW   27,788.19 (+0.02%)
QQQ   201.08 (-0.25%)
CGC   15.95 (-13.78%)
BABA   183.04 (+0.31%)
GE   11.25 (-0.35%)
T   39.01 (-0.38%)
F   8.87 (+0.57%)
ACB   3.32 (-6.48%)
PRI   128.22 (-0.30%)
BAC   32.75 (-0.15%)
DIS   149.26 (+0.36%)
Log in

Medical Transcription Billing Stock Price, Forecast & Analysis (NASDAQ:MTBC)

$3.80
+0.23 (+6.44 %)
(As of 11/14/2019 08:59 AM ET)
Today's Range
$3.61
Now: $3.80
$4.19
50-Day Range
$3.57
MA: $3.87
$4.18
52-Week Range
$3.25
Now: $3.80
$5.50
Volume222,000 shs
Average Volume35,489 shs
Market Capitalization$46.44 million
P/E RatioN/A
Dividend YieldN/A
Beta1.71
Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company's offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform. Read More…

Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MTBC
CUSIPN/A
Phone732-873-5133

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$50.55 million
Cash Flow$0.07 per share
Book Value$3.06 per share

Profitability

Net Income$-2,140,000.00

Miscellaneous

Employees2,400
Market Cap$46.44 million
Next Earnings Date3/18/2020 (Estimated)
OptionableNot Optionable

Receive MTBC News and Ratings via Email

Sign-up to receive the latest news and ratings for MTBC and its competitors with MarketBeat's FREE daily newsletter.


Medical Transcription Billing (NASDAQ:MTBC) Frequently Asked Questions

What is Medical Transcription Billing's stock symbol?

Medical Transcription Billing trades on the NASDAQ under the ticker symbol "MTBC."

How were Medical Transcription Billing's earnings last quarter?

Medical Transcription Billing Corp (NASDAQ:MTBC) issued its earnings results on Wednesday, November, 6th. The technology company reported ($0.14) earnings per share for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.14). The technology company earned $16.85 million during the quarter, compared to analysts' expectations of $16.06 million. Medical Transcription Billing had a negative return on equity of 8.85% and a negative net margin of 5.01%. View Medical Transcription Billing's Earnings History.

When is Medical Transcription Billing's next earnings date?

Medical Transcription Billing is scheduled to release their next quarterly earnings announcement on Wednesday, March 18th 2020. View Earnings Estimates for Medical Transcription Billing.

What guidance has Medical Transcription Billing issued on next quarter's earnings?

Medical Transcription Billing updated its FY 2019 earnings guidance on Tuesday, October, 15th. The company provided EPS guidance of for the period. The company issued revenue guidance of $62.677 million, compared to the consensus revenue estimate of $64.4 million.

What price target have analysts set for MTBC?

3 brokerages have issued twelve-month target prices for Medical Transcription Billing's shares. Their forecasts range from $6.00 to $6.00. On average, they anticipate Medical Transcription Billing's share price to reach $6.00 in the next year. This suggests a possible upside of 57.9% from the stock's current price. View Analyst Price Targets for Medical Transcription Billing.

What is the consensus analysts' recommendation for Medical Transcription Billing?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medical Transcription Billing in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medical Transcription Billing.

Has Medical Transcription Billing been receiving favorable news coverage?

Headlines about MTBC stock have been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Medical Transcription Billing earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned media coverage about the technology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Medical Transcription Billing.

Are investors shorting Medical Transcription Billing?

Medical Transcription Billing saw a decline in short interest in the month of October. As of October 31st, there was short interest totalling 42,000 shares, a decline of 64.7% from the September 30th total of 119,000 shares. Based on an average daily volume of 29,800 shares, the short-interest ratio is currently 1.4 days. Currently, 0.7% of the company's shares are short sold. View Medical Transcription Billing's Current Options Chain.

Who are some of Medical Transcription Billing's key competitors?

What other stocks do shareholders of Medical Transcription Billing own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Transcription Billing investors own include BlackBerry (BB), NVIDIA (NVDA), Sophiris Bio (SPHS), Verastem (VSTM), Advanced Micro Devices (AMD), Microbot Medical (MBOT), Micron Technology (MU), Alibaba Group (BABA), Etsy (ETSY) and Interpace Diagnostics Group (IDXG).

How do I buy shares of Medical Transcription Billing?

Shares of MTBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Medical Transcription Billing's stock price today?

One share of MTBC stock can currently be purchased for approximately $3.80.

How big of a company is Medical Transcription Billing?

Medical Transcription Billing has a market capitalization of $46.44 million and generates $50.55 million in revenue each year. The technology company earns $-2,140,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis. Medical Transcription Billing employs 2,400 workers across the globe.View Additional Information About Medical Transcription Billing.

What is Medical Transcription Billing's official website?

The official website for Medical Transcription Billing is http://www.mtbc.com/.

How can I contact Medical Transcription Billing?

Medical Transcription Billing's mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company can be reached via phone at 732-873-5133.


MarketBeat Community Rating for Medical Transcription Billing (NASDAQ MTBC)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  206 (Vote Outperform)
Underperform Votes:  209 (Vote Underperform)
Total Votes:  415
MarketBeat's community ratings are surveys of what our community members think about Medical Transcription Billing and other stocks. Vote "Outperform" if you believe MTBC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTBC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/14/2019 by MarketBeat.com Staff

Featured Article: Operating Income

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel